The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal
about
Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter CohortIncidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatmentTransmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapyTrends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesEtravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infectionMissing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection.Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy.Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response.Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patientsThe prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.The demise of multidrug-resistant HIV-1: the national time trend in Portugal.Transmitted human immunodeficiency virus-1 drug resistance in a cohort of men who have sex with men in Belo Horizonte, Brazil--1996-2012Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infection.CCR5 inhibitors in HIV-1 therapy.Etravirine for the treatment of HIV/AIDS.Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan.Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.Mode of antiviral action of silver nanoparticles against HIV-1.Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: analysis from a national drug-resistance database (ARCA).Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir.
P2860
Q28475698-36D9244C-1201-40A2-A21A-995FC36721CDQ28487377-CA17C40E-B9D1-4E35-9575-06E377319702Q28487475-5F18A086-F9CE-4421-B451-4E41F5C2E90AQ28488769-F64A8385-59FC-47A9-92E2-8FC709095C48Q28539169-D534007C-2469-40FC-840C-6EB1761F197FQ33973857-575976D9-6710-4120-BEE2-89DC436E54D0Q33981074-821FCA98-6315-4FB3-9F9C-A5634A49721DQ34070640-B5D36B22-17C7-4FAD-912B-E877379DA6F4Q34468059-250856E7-86A6-47D5-ACC5-671213C22346Q34684386-41D485D4-0ADF-45B5-9E0A-26069B52A0C7Q36367759-AEAF9D86-5558-410C-B945-EAAAE914FD37Q36553994-29CD1F7C-2BC5-40F3-8FBF-68EDBD9C8F67Q36675129-F8EDCD8D-D2E2-4CDD-B527-3F3ACE1DA0ABQ37675040-69BE1EA2-C6C1-4745-8FD7-21E9456B56E7Q38003399-8BD77306-1B2E-4543-AD9A-AD6C63314F09Q38089881-C4099393-CEE9-4C71-83B0-B2C8F4604939Q38096459-4369C8E2-439C-4F41-8984-2DE61CFD2D47Q38405467-509E1D04-860D-4C2F-AA61-D1F7CE39A9F4Q38428118-44BB21ED-63D6-4A6C-8901-A97CFFDD3C0AQ39160530-38A65795-D75E-450D-9D4B-9B6428550F02Q42214788-4625048D-82C7-4319-9EE3-F531926C414EQ42704290-8EF03ADD-6722-4A79-A76D-E4C32608C4A8
P2860
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The incidence of multidrug and ...... r time (2001-2006) in Portugal
@en
The incidence of multidrug and ...... tients is decreasing over time
@nl
type
label
The incidence of multidrug and ...... r time (2001-2006) in Portugal
@en
The incidence of multidrug and ...... tients is decreasing over time
@nl
prefLabel
The incidence of multidrug and ...... r time (2001-2006) in Portugal
@en
The incidence of multidrug and ...... tients is decreasing over time
@nl
P2093
P2860
P356
P1433
P1476
The incidence of multidrug and ...... r time (2001-2006) in Portugal
@en
P2093
Ana Patricia Carvalho
Jurgen Vercauteren
Kamal Mansinho
Koen Deforche
Kristof Theys
Luis Miguel Duque
Michiel Debruyne
Susana Peres
P2860
P2888
P356
10.1186/1742-4690-5-12
P577
2008-02-01T00:00:00Z
P5875
P6179
1036035198